Achema middle east

Press Releases

AI and analytics partnership to accelerate healthcare innovation at the University of Cambridge

The Maxwell Centre, University of Cambridge and SAS, leaders in data and AI, are establishing a new collaboration hub to advance opportunities for the healthcare sector. Today, SAS and the Maxwell Centre at the University of Cambridge announce a partnership...

Syntegon launches modular bioprocessing platform at Achema

Innovative modular concept shortens lead times and lowers costs Full functionality off-the-shelf for both clinical and commercial production Fully integrated and automated for maximum efficiency and quality assurance Waiblingen/Frankfurt (Germany), June 10, 2024. Achema 2024 has opened its doors...

ChargePoint Technology launches new robotic solution to help transform the future of GMP manufacturing

ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing safety and efficiency in solid dosage drug manufacturing. The new robotics solution will improve efficiency for manufacturers looking...

Zeton unveils revolutionary ContiUnity modular system at the ACHEMA 2024

Zeton., a global leader in the design and fabrication of lab-scale systems, pilot plants, demonstration plants, and small production plants, proudly announces the official launch of its groundbreaking product, ContiUnity®, at the ACHEMA 2024 exhibition in Frankfurt am Main...

QIAGEN broadens syndromic testing menu in Malaysia with the MDA approval of advanced QIAstat-Dx respiratory panel

The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia expanded to 23 pathogens, now includes Chlamydophila pneumoniae Crucial during the Monsoon Season, providing comprehensive result for timely clinical decision-making and rapid therapeutic intervention QIAstat-Dx Respiratory SARS-CoV-2...

Renovaro Inc and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

Renovaro Inc and the Amsterdam UMC Cancer Center announced an intended partnership and therefore signed an MoU to establish a joint company based in the Netherlands aimed at pioneering the next generation of personalized cancer immunotherapy. Both Renovaro and...

Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines

Eli Lilly and Company announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion. This expansion will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »